These can hinder your weight loss and overall health goals
By promoting evidence-based prescribing, evaluating cost-effectiveness, ensuring equitable access, and staying informed in the market, Excellus BCBS can play a pivotal role in navigating the complexities of this growing trend while prioritizing member care
Subsequently, many different GLP-1R agonists were developed and approved, including : extended release exenatide (exenatide XR), liraglutide, lixisenatide , dulaglutide , and semaglutide (Table 1)
S.KarnsR.Wikenheiser-BrokampK
Ask your doctor about strategies to manage potential side effects and weigh the risks and benefits specific to your condition